London (PRWEB) October 14, 2013
India is characterized by the presence of a large diabetic population. The country’s status as the diabetes capital of the world has made the need for diabetes prevention and screening very important. Naturally, tests for measuring the blood glucose levels are highly demanded within the country. HbA1c testing in the country is also benefiting from this trend. The ability to measure one’s blood glucose levels over a period of 3 months has made it a test favored by many diabetics as well as people who believe they are at high risk of developing diabetes. The market for HbA1c testing has been growing steadily and with the awareness level regarding it increasing rapidly, the market is set to boom in a few years.
Although the test is considered to be very useful for diabetes screening as well as monitoring the diabetes status of a patient, its much higher cost compared to a simple blood sugar level test can act as a hindrance to its greater acceptance. However, the need to go for HbA1c tests only 3-4 times a year unlike the blood sugar level test which may have to be done on a monthly basis may work in favour of the former. Moreover, HbA1c tests give a clearer picture of the diabetes status of a patient as it a measurement of the glucose levels over a period of 3 months. Several physicians also prescribe this test to their patients which in turn will increase its demand and thereby drive growth in the market.
Several large diagnostic chains offer these tests in India. Majority of the patients going for this test are confirmed diabetics while very few non-diabetics go for this test. Most of the patients visiting laboratories for HbA1c tests have been prescribed to go for the test by a physician with very few people opting for the test on their own. But with increasing awareness among people, this ratio is likely to change and many more people are expected to go for the test independently.
Slide 1: Executive Summary
Macro Economic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2009-10 – 2012-13), Inflation Rate: Monthly (Oct 2012 – Mar 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011 - Feb 2012), Exchange Rate: Monthly (Nov 2012- Apr 2013)
Slide 4: Lending Rate: Annual (2008-09 – 2011-12), Trade Balance: Annual (2009-10 - 2012-13), FDI Annual (2009-10 – 2012-13)
Slide 5: Healthcare Industry Overview, Healthcare Market Size & Growth (Value-Wise 2012-2017e), Healthcare Market –Segmentation (2011-12)
Slide 6: FDI Inflow in Indian Healthcare Segments
Slide 7: Healthcare Expenditure of Population by Economic Standard
Slide 8: Diabetes Prevalence in Around the World
Slide 9: Diabetes – Global Overview, Global Prevalence of Diabetes (2011-2020e)
Slide 10: Region-Wise Diabetes Prevalence (2012), Region-Wise Undiagnosed Cases of Diabetes (2012)
Slide 11: HbA1c Test – Overview
Slide 12: Diagnostic Service – Market Overview, Market Size & Growth (2012 to 2017e), Diagnostic Service Market-Split (2012), Diagnostic Service Market – Segmentation (2012)
Slide 13: Point-of-Care Testing – Market Overview, Market Size & Growth (2011 to 2017e)
Slide 14: SMBG – Market Overview, Market Size & Growth (2011 to 2017e)
Slide 15: SMBG – Market Overview, Market Size & Growth (2011 to 2017e), HbA1c Tests Conducted Annually (2011-2017e)
Drivers & Challenges
Slide 16: Drivers & Challenges – Summary
Slide 17-21: Drivers
Slide 22-25: Challenges
Diabetes Disease Trends
Slide 26: Trends – Summary
Slide 27-33: Diabetes Related Diseases – Overview, Symptoms and Prevalence
Slide 34-36: Government Legislation
Slide 37: Comparative Study of the Prevalent HbA1c Testing Technologies
Slide 38: Major Players – High-performance Liquid Chromatography
Slide 39-40: HPLC Adoption by Different Hospitals and Diagnostic Centers
Slide 41: NGSP Certification, List of NGSP Certified Companies
Slide 42: Porter’s Five Forces Analysis
Slide 43: Diagnostic Service Providers – Summary
Slide 44-47: Competitive Benchmarking
Slide 48-83: Major Diagnostic Service Players
Slide 84: HbA1c Analyzer and Reagent Manufacturers – Summary
Slide 85-127: Major HbA1c Analyzer and Reagent Players
Slide 128: Strategic Insights
Slide 129: Appendix
Slide 130: Sources of Information
1. Abbott India Ltd.
2. Axis-Shield plc
3. Siemens Ltd.
4. Tosoh Corporation
1. Apollo Health and Life Styles Ltd.
2. Dr Lal Pathlabs Pvt. Ltd.
3. Metropolis Healthcare Ltd.
4. Quest Diagnostics India Pvt. Ltd.
5. S Serum Analysis Centre Pvt. Ltd.
6. SRL Diagnostics Pvt. Ltd.
7. Thyrocare Diagnostics Pvt. Ltd.
8. Bayer Pharmaceuticals Pvt. Ltd.
9. Beckman Coulter India Pvt. Ltd.
10. Bio-Rad Laboratories (India) Pvt. Ltd.
11. Transasia Bio-medicals Ltd. Trivitron Healthcare Pvt. Ltd.
Read the full report:
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48